Bridging communities in the field of nanomedicine

An early dialogue between nanomedicine developers and regulatory authorities are of utmost importance to anticipate quality and safety requirements for these innovative health products. In order to stimulate interactions between the various communities involved in a translation of nanomedicines to c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Regul Toxicol Pharmacol
Autori principali: Halamoda-Kenzaoui, Blanka, Baconnier, Simon, Bastogne, Thierry, Bazile, Didier, Boisseau, Patrick, Borchard, Gerrit, Borgos, Sven Even, Calzolai, Luigi, Cederbrant, Karin, Di Felice, Gabriella, Di Francesco, Tiziana, Dobrovolskaia, Marina A., Gaspar, Rogério, Gracia, Belén, Hackley, Vincent A., Leyens, Lada, Liptrott, Neill, Park, Margriet, Patri, Anil, Roebben, Gert, Roesslein, Matthias, Thürmer, René, Urbán, Patricia, Zuang, Valérie, Bremer-Hoffmann, Susanne
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6597901/
https://ncbi.nlm.nih.gov/pubmed/31051191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yrtph.2019.04.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi